Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
02/2007
02/21/2007CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/21/2007CN1301254C Preparation of catifloxacin and purifying method
02/20/2007US7179921 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment
02/20/2007US7179920 [4-(5-Chloro-2-hydroxy-phenyl)-2-oxo-6-trifluoromethyl- 1,2-dihydro-quinolin-3-ylsulfanyl]-acetic acid for example; potassium channel modulators for treating erectile dysfunction and irritable bowel syndrome
02/20/2007US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
02/20/2007US7179816 Chemical derivatives and their application as antitelomerase agents
02/20/2007US7179805 Microbiocides; bactericides
02/20/2007US7179794 Antibiotics; bactericides
02/20/2007CA2230770C Amidophosphinephosphinite compounds
02/15/2007WO2007017414A1 Substituted malononitrile compounds for combating animal pests
02/15/2007WO2006113606A3 Histone deacetylase inhibitors
02/15/2007WO2006103120A3 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
02/15/2007WO2005123703A8 Alkynyl derivatives as modulators of metabotropic glutamate receptors
02/15/2007US20070037976 Method for producing an optically active nitro compound
02/15/2007US20070037849 1-(2-chloro-4-hydroxyphenyl)-3-cyclopropylurea; angiogenesis neoplasia
02/15/2007US20070037830 2-Adamantyl derivatives as p2X7 receptor antagonists.
02/15/2007US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders
02/15/2007US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders
02/15/2007CA2618888A1 Acyltryptophanols for fertility control
02/14/2007EP1752455A2 Chemokine receptor binding heterocyclic compounds
02/14/2007EP1751149A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
02/14/2007EP1751115A1 Theramutein modulators
02/14/2007EP1751091A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
02/14/2007EP1751086A2 DIAMINE ß2 ADRENERGIC RECEPTOR AGONISTS
02/14/2007EP1750704A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
02/14/2007EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
02/14/2007EP1017676B1 Method for the synthesis of quinoline derivatives
02/14/2007EP0999256B1 Compounds for organic el element and organic el element
02/14/2007CN1914206A 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
02/14/2007CN1914195A Substituted quinoline compounds
02/14/2007CN1914176A Process for preparing aripiprazole
02/14/2007CN1914175A Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril
02/14/2007CN1914174A Methods of preparing aripiprazole crystalline forms
02/14/2007CN1914173A Quinolines useful in treating cardiovascular disease
02/14/2007CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists
02/14/2007CN1913880A Method for treating ADAMTS-5-associated disease
02/13/2007US7176315 Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and salts thereof, useful in the treatment of cancer
02/13/2007US7176314 Inflammation modulators
02/13/2007US7176313 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance
02/13/2007US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
02/13/2007US7176220 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
02/13/2007US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases
02/13/2007US7176207 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis
02/13/2007US7176206 Antibiotics
02/13/2007CA2220649C 4-hydroxy-piperidine derivatives
02/13/2007CA2122236C Quinolines and their analogs
02/08/2007WO2007016609A2 Method for the synthesis of quinoliνe derivatives
02/08/2007WO2007015567A1 Cyclic amine compound
02/08/2007WO2007014941A2 Quinoline derivatives as antibacterial agents
02/08/2007WO2007014885A1 Antibacterial quinoline derivatives
02/08/2007WO2007014607A1 Quadratic acid derivatives in the form of a protein kinase inhibitors
02/08/2007WO2006110477A3 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
02/08/2007US20070032505 Crystalline form of gatifloxacin
02/08/2007US20070032504 Polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline
02/08/2007US20070032474 Use of a compound of formula 1 for making a pharmaceutical composition
02/08/2007CA2617256A1 Cyclic amine compound
02/08/2007CA2616682A1 Squaric acid derivatives as protein kinase inhibitors
02/08/2007CA2615903A1 Quinoline derivatives as antibacterial agents
02/08/2007CA2615901A1 Quinoline derivatives as antibacterial agents
02/08/2007CA2614981A1 Antibacterial quinoline derivatives
02/07/2007EP1748987A2 2-propene-1-ones as hsp 70 inducers
02/07/2007EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase
02/07/2007EP1242382B1 Tricyclic protein kinase inhibitors
02/07/2007CN1910181A Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
02/07/2007CN1910172A 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines
02/07/2007CN1910154A Quinoline derivatives for use as mycobacterial inhibitors
02/07/2007CN1910153A Derivatives of pyridine and quinoline
02/07/2007CN1910137A Aryl aniline derivatives as beta2 adrenergic receptor agonists
02/07/2007CN1909907A Quinoline derivatives and use thereof as mycobacterial inhibitors
02/06/2007US7173136 3-Cyano-quinoline derivatives
02/06/2007US7173135 Substituted 3-cyanoquinolines as MEK inhibitors
02/06/2007US7173130 Detection of transmembrane potentials by optical methods
02/06/2007US7173042 Quinoline inhibitors of cGMP phosphodiesterase
02/06/2007US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted
02/06/2007US7173036 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
02/06/2007US7173035 Arylsulfonamide compounds
02/01/2007US20070027318 Quinoline derivatives and quinazoline derivatives
02/01/2007US20070027184 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
02/01/2007US20070027158 High affinity small molecule C5a receptor modulators
02/01/2007US20070027141 Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors
02/01/2007US20070027139 Piperazinyl-quinoline derivatives useful for the treatment of cns disorders
02/01/2007US20070026384 Detection of transmembrane potentials by optical methods
01/2007
01/31/2007EP1748046A2 Inhibitors of histone deacetylase
01/31/2007EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
01/31/2007EP1747195A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
01/31/2007EP1747066A1 Collector for sulfidic ores
01/31/2007EP1509516B1 Inhibitors of the gpib -vwf interaction, their preparation and use
01/31/2007CN1906169A Therapeutic agents I
01/31/2007CN1906168A Methods and compositions for selectin inhibition
01/31/2007CN1905881A Diamine and iminodiacetic acid hydroxamic acid derivatives
01/31/2007CN1905873A Bicyclic inhibitors of MEK and methods of use thereof
01/31/2007CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
01/31/2007CN1297542C Process for preparation of 6-fluoro-1,4-dihydro-4-oxo quinoline-3-carboxylic acid derivatives
01/31/2007CN1297541C Method for preparing CETP inhibitors
01/30/2007US7169951 Quinazoline derivatives and pharmaceutical applications thereof
01/30/2007US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants
01/30/2007US7169927 Heterocyclic amides or prodrugs used in the treatment of diabetes, insulin resistance, metabolic disorders and obesity
01/30/2007US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders
01/30/2007US7169789 Quinoline derivatives and quinazoline derivatives
01/30/2007CA2440383C 7,9-substituted tetracycline compounds